Your browser doesn't support javascript.
loading
Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18-59 years) adults.
Andermann, Eva; Rosenfeld, William; Penovich, Patricia; Rogin, Joanne; Cendes, Fernando; Carreño, Mar; Ramsay, R Eugene; Ben-Menachem, Elinor; Gama, Helena; Rocha, Francisco; Soares-da-Silva, Patrício; Tosiello, Robert; Blum, David; Grinnell, Todd.
Afiliação
  • Andermann E; Neurogenetics Unit and Epilepsy Research Group, Montreal Neurological Institute and Hospital, Departments of Neurology & Neurosurgery and Human Genetics, McGill University, Montreal, QC, Canada. Electronic address: eva.andermann@mcgill.ca.
  • Rosenfeld W; The Comprehensive Epilepsy Care Center for Children and Adults, St Louis, MO, USA. Electronic address: werosenfeld@msn.com.
  • Penovich P; Minnesota Epilepsy Group, P.A., St Paul, MN, USA. Electronic address: ppenovich@mnepilepsy.net.
  • Rogin J; Midwest Center for Seizure Disorders, Minneapolis Clinic of Neurology, Golden Valley, MN, USA. Electronic address: Joanne.Rogin@Mpls-clinic.com.
  • Cendes F; Department of Neurology, FCM, UNICAMP - Universidade Estadual de Campinas, Sao Paulo, Brazil. Electronic address: fcendes@unicamp.br.
  • Carreño M; Hospital Clinic, Barcelona, Spain. Electronic address: MCARRENO@clinic.cat.
  • Ramsay RE; Epilepsy Institute, Ochsner Baptist Medical Center, New Orleans, LA, USA. Electronic address: eramsay@ochsner.org.
  • Ben-Menachem E; Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. Electronic address: Elinor.Ben-Menachem@neuro.gu.se.
  • Gama H; BIAL - Portela & C(a), S.A., S. Mamede do Coronado, Portugal. Electronic address: Helena.gama@bial.com.
  • Rocha F; BIAL - Portela & C(a), S.A., S. Mamede do Coronado, Portugal. Electronic address: francisco.rocha@bial.com.
  • Soares-da-Silva P; BIAL - Portela & C(a), S.A., S. Mamede do Coronado, Portugal. Electronic address: psoares.silva@bial.com.
  • Tosiello R; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. Electronic address: Robert.Tosiello@sunovion.com.
  • Blum D; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. Electronic address: David.Blum@sunovion.com.
  • Grinnell T; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. Electronic address: todd.grinnell@sunovion.com.
Epilepsy Res ; 169: 106478, 2021 01.
Article em En | MEDLINE | ID: mdl-33338829

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dibenzazepinas Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Epilepsy Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dibenzazepinas Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Epilepsy Res Ano de publicação: 2021 Tipo de documento: Article